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Patients with coexisting cataract and vitreoretinal dis-
eases may benefit from one combined surgery instead
of separate surgical procedures. The combined surgery
entails less anesthetic risk and facilitates immediate
diagnosis and treatment of vitreoretinal complications
associated with the underlying ocular diseases [1].
For eyes with proliferative diabetic retinopathy (PDR),
there have been concerns that diabetic retinopathy may
worsen following cataract extraction [2,3], and that
there may be an increased incidence of rubeosis iridis
and neovascular glaucoma (NVG) following removal
of the crystalline lens in vitrectomized eyes [4–6].
Intraocular lens (IOL) implantation in eyes of PDR
patients is controversial [7]. However, some studies
have shown that posterior chamber intraocular lens
(PCIOL) are well tolerated in eyes with nonprolifera-
tive as well as quiescent PDR [8–10]. In Kadonosono
et al’s [11] report, the incidence of postoperative rubeo-
sis was significantly lower, and the visual results were
satisfactory with vitrectomy combined with phaco-
emulsification (phacovitrectomy) and PCIOL implan-
tation for PDR. In this study, we retrospectively
compared vitrectomy alone and vitrectomy com-
bined with phacoemulsification and IOL implanta-
tion with regard to both complications and results.
PATIENTS AND METHODS
We retrospectively reviewed patients with PDR who
were surgically treated by one of the authors (Wu) 
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There have been concerns that there may be an increased incidence of iris neovascularization (NV)
following lens removal in patients with proliferative diabetic retinopathy (PDR). In this study, we
retrospectively compared vitrectomy alone and vitrectomy combined with phacoemulsification
(phacovitrectomy) and intraocular lens implantation regarding both complications and results. Fifty-
three eyes for vitrectomy group and 31 eyes for phacovitrectomy group were included. Postoperative
iris and angle NV were found in eight (15.1%) eyes in the first group and no (0%) eyes in the second.
The incidence was significantly lower (p<0.05) in the phacovitrectomy group. The final vision gain
of one or more lines was found in 17 (32.1%) and 21 (67.7%) eyes, respectively. There was significantly
better vision improvement in the phacovitrectomy group. We consider the combined procedure to
be useful as an alternative surgical treatment for patients with PDR and cataract formation.
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at the Department of Ophthalmology, Kaohsiung
Medical University Hospital, during the 90-month
period between January 1996 and June 2003.
The main surgical technique comprised a three-
port pars plana vitrectomy; after removal of the pro-
liferating membrane and excision of the posterior
hyaloid membrane, vitreous and preretinal hemor-
rhages were cleared up by back flush needle. Patients
were divided into two groups according to the proce-
dures they received. In the vitrectomy alone group,
removal of the vitreous and photocoagulation of the
peripheral retina were carried out from the equato-
rial region of the peripheral retina with as little injury
to the lens as possible. In the phacovitrectomy group,
phacoemulsification through a small self-sealing scle-
ral incision was performed, followed by pars plana
vitrectomy as mentioned earlier. No extra care was
needed for avoiding damage to the lens because it
had already been removed in this case. A PCIOL was
implanted in the final phase of the surgery.
The patients’ selection criteria included: (1) visual
acuity ≤ 0.3 for at least 3 months prior to surgery, (2)
vitreous opacity or preretinal hemorrhage obscuring
details of fundus, (3) no evidence of severe fibrovascu-
lar proliferation or tractional RD on ultrasonographic
evaluation, (4) no evidence of neovascular proliferation
on iris and angle.
Preoperative evaluation of the patients included:
(1) basic personal profiles (age, sex) and medical his-
tory, (2) best corrected visual acuity, (3) examination
of anterior segment and measurement of intraocular
pressure (IOP), (4) type and degree of cataract, (5) vit-
reoretinal anatomy based on fundoscopic or ultra-
sonic evaluation.
Postoperative evaluation included: (1) best cor-
rected visual acuity, (2) postoperative complications
including transient increased intraocular pressure
(IIOP), rubeosis iridis, NVG, macular edema, hyphema,
phthisis, and recurrent vitreous hemorrhage (VH).
Profiles for the two groups were collected and
compared using Fisher’s exact probability test regard-
ing postoperative complications and final vision
improvements.
RESULTS
Eighty-four patients were enrolled. Fifty-three eyes
received vitrectomy alone and 31 eyes received 
vitrectomy combined with phacoemulsification and
PCIOL implantation.
The demographic data for vitrectomy alone and
phacovitrectomy groups are shown in Table 1. Mean
patient age was 54.1 years (range, 28–70 years) in the
vitrectomy alone group and 62.5 years (range, 31–75
years) in the phacovitrectomy group. In the vitrectomy
alone group, 20 of 26 eyes whose lens were clear at the
time of preoperative examination developed nuclear or
posterior subcapsular cataracts after surgery. Almost
all eyes with cataracts in the vitrectomy alone group
showed progression of cataract after surgery.
Postoperative iris and angle neovascularization
(NV) were found in eight (15.1%) eyes in the vitrectomy
alone group and no (0%) eyes in the phacovitrectomy
group. Thus, the incidence was significantly lower
(p < 0.05) in the phacovitrectomy group (Table 2). Post-
operative recurrent VH was found in 19 eyes (35.8%)
in the vitrectomy alone group and in two eyes (6.5%)
in the phacovitrectomy group. The incidence was 
significantly lower in the phacovitrectomy group
(p<0.05) (Table 2). Other complications included post-
operative transient IIOP, glaucoma, macular edema,
hyphema, and phthisis; there were no significant dif-
ferences between the two groups for these complica-
tions (Table 2).
In the vitrectomy alone group, 17 (32.1%) eyes
had a final vision improvement of one or more lines.
In the phacovitrectomy group, 21 (67.7%) eyes had a
final vision improvement of one or more lines. There
was significantly better vision improvement in the
phacovitrectomy group (Table 3). More patients’
vision remained unchanged or even decreased in 
the vitrectomy alone group (67.9%) than the phaco-
vitrectomy group (32.3%). Forty-six of 53 eyes in the
vitrectomy alone group showed significant cataract
Table 1. Demographic data of the two groups
Vitrectomy alone Phacovitrectomy 
(n = 53) (n = 31)
Gender
Male 25 24
Female 28 7
Age (yr) 54.1 ± 11.35 62.5 ± 8.2
Male 52.6 ± 11.9 62.6 ± 7.8
Female 55.8 ± 10.7 60.2 ± 11.2
Follow-up 16.1 ± 8.5 15.6 ± 7.0
duration (mo)
Iris neovascularization after vitrectomy
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progression postoperatively that might have been
partly responsible for the decreased vision.
DISCUSSION
It was previously reported that there are certain
advantages to combining vitrectomy, lensectomy,
and IOL implantation in the treatment of diabetic
retinopathy [12–14]. In this study, we retrospectively
compared visual results and complications between
the vitrectomy alone and vitrectomy combined with
phacoemulsification and IOL implantation groups.
The results showed that the combined procedure
group had a lower incidence of postoperative iris
rubeosis and angle NV than the vitrectomy alone
group, and had a better visual outcome.
The incidence of iris NV after vitrectomy of PDR
ranged from 8% to 26% in phakic eyes and from 31%
to 55% in aphakic eyes in previous reports [5–16]. The
risk factors of these postoperative iris NV included
previous severe retinal NV and incomplete excision of
peripheral vitreous. Combining vitrectomy and phaco-
emulsification lensectomy is advantageous because
removal of the lens ensures better operative visibility
and allows more reliable vitrectomy maneuvers. This
procedure provides better visualization of the fundus,
and enables surgeons to reattach the retina successfully
and perform sufficient peripheral retinal photocoag-
ulation. These factors may lead to the lower incidence
of iris rubeosis [17].
Another theory on the pathogenesis of iris rubeo-
sis or angle NV on diabetic retinopathy was that the
progression of NV is the result of an increase in vas-
cular permeability factors, such as vascular endothe-
lial growth factor and interleukin-6 [18,19]. Complete
removal of the vitreous that contains the intrinsic
permeability factors is probably a contributing factor
in decreasing the incidence of postoperative iris and
angle NV.
The better visual outcome of the phacovitrectomy
group may be attributed to complete VH clearance by
vitrectomy as well as prevention of postoperative
cataract formation due to removal of the lens. Most
eyes in the vitrectomy alone group had postoperative
progression of nuclear or subcapsular cataracts result-
ing in impairment of visual acuity, which was not an
issue in the phacovitrectomy group.
The main limitation of this study is its retrospec-
tive nature. For patients’ best benefit, we selected
cases with more significant cataract to perform pha-
covitrectomy surgery, and this tendency resulted in
an age difference between the two study groups. At
the same time, the better visual outcome in the pha-
covitrectomy group might be partly or solely due to
lens extraction. But the advantage of our study is the
relatively large number of patients studied. We found 
a significantly lower incidence of postoperative recur-
rent VH and iris NV in the phacovitrectomy group,
which suggests that combining lens extraction and
vitrectomy procedures in diabetic patients may be
better than doing them separately.
Vitrectomy combined with phacoemulsification
and IOL implantation reduces the incidence of postop-
erative iris and angle NV and yields more satisfactory
Table 2. Comparison of postoperative complications between the two groups
Vitrectomy alone (n = 53) Phacovitrectomy (n = 31) 
p
n (%) n (%)
Iris NV 8 (15.1) 0 0.020
Recurrent VH 19 (35.8) 2 (6.5) 0.002
NVG 1 (1.9) 0 0.631
Transient IIOP 5 (9.4) 2 (6.5) 0.486
Macular edema 1 (1.9) 0 0.631
Hyphema 1 (1.9) 0 0.631
Phthisis 2 (3.8) 0 0.395
NV = neovascularization; VH = vitreous hemorrhage; NVG = neovascular glaucoma; IIOP = increased intraocular pressure.
Table 3. Comparison of final vision improvement
between the two groups
Vitrectomy alone Phacovitrectomy
(n = 53) (n = 31) p
n (%) n (%)
< 1 line 36 (67.9) 10 (32.3) 0.003
≥ 1 line 17 (32.1) 21 (67.7)
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visual results. We consider the combined procedure
to be useful as an alternative surgical treatment for
patients with PDR and cataract formation.
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